Preserving blood safety against emerging retroviruses

Transfusion

Volumn 46, Issue 8, 2006, Pages 1276-1278

  Heneine, Walid ^a   Kuehnert, Matthew J ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD ANALYSIS; BLOOD TRANSFUSION; DISEASE TRANSMISSION; EDITORIAL; HEALTH HAZARD; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENICITY; PREVALENCE; RETROVIRUS; RISK ASSESSMENT; SAFETY; SCREENING TEST; VIRUS INFECTION; VIRUS TRANSMISSION;

ANIMALS; ANIMALS, ZOO; ANTIBODIES, VIRAL; BLOOD PRESERVATION; BLOOD TRANSFUSION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; HUMANS; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; RETROVIRIDAE INFECTIONS; RNA, VIRAL; SPUMAVIRUS; ZOONOSES;

EID: 33746361166     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00925.x     Document Type: Editorial

References (17)

1. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonoses: scientific and public health implications. Science 2000;287:607-14.
2. Salemi M, Van Dooren S, Vandamme AM. Origin and evolution of human and simian T-Cell lymphotropic viruses. AIDS Rev 1999;1:131-9.
3. Slattery JP, Franchini G, Gessain A. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/ lymphotropic viruses. Genome Res 1999;9:525-40.
4. Heneine W, Switzer WM, Sandstrom P, et al. Identification of a human population infected with simian foamy viruses. Nat Med 1998;4:403-7.
5. Wolfe ND, Switzer WM, Carr JK, et al. Naturally acquired simian retrovirus infections in central African hunters. Lancet 2004;363:932-7.
6. Wolfe N, Heneine W, Carr JK, et al. Emergence of novel primate T lymphotropic viruses among Central African primate hunters. Proc Natl Acad Sci U S A 2005;102:7994-9.
7. Switzer WM, Bhullar V, Shanmugam V, et al. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol 2004;78:2780-9.
8. Brooks JI, Rudd EW, Pilon RG, Smith JM, et al. Cross-species retroviral transmission from macaques to human beings. Lancet 2002;360:387-8.
9. Jones-Engel L, Engel GA, Schillaci MA. Primate to human retroviral transmission in Asia. Emerg Infect Dis 2005;11: 1028-35.
10. Calattini S, Chevalier SA, Duprez S, et al. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2005;2:30.
11. Hussain AI, Shanmugam V, Bhullar VB, et al. Screening for simian foamy virus infection by using a combined antigen Western blot assay: evidence for a wide distribution among Old World primates and identification of four new divergent viruses. Virology 2003;309:248-57.
12. Switzer WM, Salemi M, Shanmugam V, et al. Ancient co-speciation of simian foamy virus and primates. Nature 2005;434:376-80.
13. Boneva RS, Grindon A, Horton S, et al. Simian foamy virus infection in a blood donor. Transfusion 2002;42: 886-91.
14. Khan AS, Kumar D. Simian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans. Transfusion 2006;46:1352-9.
15. Brooks JI, Merks HW, Fournier J, et al. Characterization of blood-borne transmission of simian foamy virus. Transfusion [in press].
16. Engels EA, Switzer WM, Heneine W, Viscidi RP. Serologic evidence for exposure to simian virus 40 in North American zoo workers. J Infect Dis 2004;190:2065-9.
17. United States of America, Food and Drug Administration, Blood Products Advisory Committee. 81st Meeting [transcript on the Internet]. Rockville (MD): U.S. Food and Drug Administration; 2004 Oct 21. Available from: http:// www.fda.gov/ohrms/dockets/ac/04/transcripts/2004-4074t1.DOC